Biodistribution and Dosimetry of (177)Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

The biodistribution of the anti-CD37 radioimmunoconjugate (177)Lu-tetraxetan-tetulomab ((177)Lu-DOTA-HH1) was evaluated. Biodistribution of (177)Lu-tetraxetan-tetulomab was compared with (177)Lu-tetraxetan-rituximab and free (177)Lu in nude mice implanted with Daudi lymphoma xenografts. The data sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Repetto-Llamazares, Ada H V, Larsen, Roy H, Mollatt, Camilla, Lassmann, Michael, Dahle, Jostein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624777/
https://www.ncbi.nlm.nih.gov/pubmed/23256748
http://dx.doi.org/10.2174/1874471011306010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624777/
https://www.ncbi.nlm.nih.gov/pubmed/23256748
http://dx.doi.org/10.2174/1874471011306010004

Ejemplares similares